Multiplexed Diagnostics: A $41.5 Billion Opportunity by 2032 (CAGR 14.5%)
WILMINGTON, DELAWARE, UNITED STATES, June 25, 2024 /EINPresswire.com/ -- The multiplexed diagnostics market refers to the sector within the medical diagnostics industry that focuses on the development and utilization of advanced diagnostic techniques capable of simultaneously analyzing multiple biomarkers, analytes, or targets within a single test. These diagnostic tools are designed to offer efficient, cost-effective, and comprehensive analysis, enabling the simultaneous detection of various diseases or health conditions in a single sample.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
BioMerieux SA, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Hologic Inc., Agilent Technologies, Inc., Illumina Inc., Co-Diagnostics, Inc., Bio-Rad Laboratories Inc, Diasorin S.p.A., Thermo Fisher Scientific Inc.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/15809
Multiplexed diagnostics have gained significant prominence in the field of healthcare and medicine due to their ability to provide a more comprehensive understanding of a patient's health status in a shorter period. By enabling the detection of multiple biomarkers in parallel, these tests can contribute to early disease detection, accurate diagnosis, and personalized treatment strategies, thereby improving patient outcomes.
Factors driving the growth of the multiplexed diagnostics market include the increasing prevalence of chronic and infectious diseases, the rising demand for personalized medicine, and the growing focus on improving patient care through early and accurate diagnosis. Additionally, advancements in technology, such as the development of innovative platforms for multiplexed testing, have further fueled the expansion of this market.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/15809
Technological Advancements: Ongoing advancements in technology, such as the development of microarray and next-generation sequencing (NGS) platforms, have significantly contributed to the expansion of the multiplexed diagnostics market. These technological innovations have enabled the simultaneous analysis of multiple analytes in a single test, leading to more efficient and accurate diagnoses.
Increased Demand for Personalized Medicine: With a growing emphasis on personalized medicine, there is an increased need for comprehensive diagnostic tools that can provide a detailed analysis of an individual's health status. Multiplexed diagnostics play a crucial role in enabling healthcare professionals to tailor treatment plans according to a patient's specific molecular profile and disease characteristics.
Rising Prevalence of Chronic Diseases: The global burden of chronic diseases, such as cancer, cardiovascular diseases, and autoimmune disorders, has been steadily increasing. Multiplexed diagnostics offer a valuable solution for early detection, monitoring, and management of these complex health conditions, thereby driving the demand for these advanced diagnostic tools.
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on โStrategic Developmentsโ registered by leading players of the market
๐๐ซ๐ข๐ฏ๐๐ซ๐ฌ:
Rise in prevalence of infectious diseases
The rising incidence of infectious bacterial and viral diseases impacts the marketโs demand because, in the syndromic testing, multiplex real-time PCR technique and the syndromic approach are used for molecular diagnostics of infectious diseases.
Increase in regulatory approval for acute respiratory syndrome coronavirus testing
In May 2020, biomรฉrieux SA received FDA Emergency Use Authorization (EUA) for the BIOFIRE RP2.1 panel, which is used for the detection of 22 pathogens which is causing respiratory infections, including SARS-CoV-2 for COVID-19 disease.
The regulatory authorities, such as the FDA or CE mark, provide Emergency Use Authorization (EUA) approval for commercializing SARS-CoV-2 panels and testing to detect viruses associated with COVID-19 disease, which is a driver for the growth of the market.
๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐๐ฌ:
Strategic Initiatives taken by market players
In March 2021, F. Hoffman-La Roche Ltd acquired GenMark Diagnostics, a leading multiplex molecular diagnostics provider. This acquisition has helped the company to broaden Rocheโs molecular diagnostic portfolio. These strategic initiatives taken by the market players, including focused segment product launches, are helping them expand their global reach and enhance their product portfolio and acting as an opportunity for the marketโs growth.
๐๐๐๐๐๐- ๐ ๐๐ฎ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐๐ข๐๐ซ๐๐ซ๐ฒ (๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐จ๐ง-๐๐๐ฆ๐๐ง๐, ๐ฌ๐ฎ๐๐ฌ๐๐ซ๐ข๐ฉ๐ญ๐ข๐จ๐ง-๐๐๐ฌ๐๐ ๐ฉ๐ซ๐ข๐๐ข๐ง๐ ๐ฆ๐จ๐๐๐ฅ) ๐๐๐๐๐ซ๐๐ ๐๐ฒ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
๐๐๐ญ ๐๐ง ๐๐๐๐๐ฌ๐ฌ ๐ญ๐จ ๐ญ๐ก๐ ๐ฅ๐ข๐๐ซ๐๐ซ๐ฒ ๐จ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ๐ฌ ๐๐ญ ๐๐ง๐ฒ ๐ญ๐ข๐ฆ๐ ๐๐ซ๐จ๐ฆ ๐๐ง๐ฒ ๐๐๐ฏ๐ข๐๐ ๐๐ง๐ ๐๐ง๐ฒ๐ฐ๐ก๐๐ซ๐. ๐ ๐จ๐ซ ๐ฆ๐จ๐ซ๐ ๐๐๐ญ๐๐ข๐ฅ๐ฌ, ๐๐จ๐ฅ๐ฅ๐จ๐ฐ ๐ญ๐ก๐ ๐ฅ๐ข๐ง๐ค: https://www.alliedmarketresearch.com/library-access
๐๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ ๐๐จ๐ซ๐ ๐๐๐ฉ๐จ๐ซ๐ญ:
Multiplexed Diagnostics Market: https://www.alliedmarketresearch.com/multiplexed-diagnostics-market-A15440
Healthcare BPO Market2: https://www.alliedmarketresearch.com/healthcare-bpo-market-A11012
Cardiovascular Digital Solutions Market3: https://www.alliedmarketresearch.com/cardiovascular-digital-solutions-market-A12468
๐๐๐จ๐ฎ๐ญ ๐๐ฌ:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
๐๐จ๐ง๐ญ๐๐๐ญ ๐๐ฌ:
David Correa
Wilmington, Delaware, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
1 https://www.alliedmarketresearch.com/multiplexed-diagnostics-market-A15440
2 https://www.alliedmarketresearch.com/healthcare-bpo-market-A11012
3 https://www.alliedmarketresearch.com/cardiovascular-digital-solutions-market-A12468